SAN JOSE, Calif., April 24, 2024 — FirstHive, the leading provider of customer data platform (CDP) solutions, has announced the closing of its latest funding round with Benhamou Global Ventures (BGV), Saama and Amit Singal as new lead investors. This round marks a new chapter for FirstHive as it expands in the U.S. and aims to revolutionize customer engagement for enterprises worldwide.

FirstHive was founded in 2016 by Aditya Bhamidipaty with the goal of providing modern enterprises with a single source of intelligence to unravel customer identity and streamline data within enterprises’ marketing and analytics ecosystems. The company has quickly emerged as a leader in the CDP space, empowering brands to create deeply personalized customer experiences and drive meaningful engagement across channels.

“In a cookieless world, CDPs have become indispensable for enterprises looking to embrace generative AI,” commented General Partner at BGV Yashwanth Hemaraj. “FirstHive leverages first-party data to create deeply personalized experiences, turning the absence of third-party cookies into an opportunity for more meaningful customer engagement, automating decisions and personalizing marketing. At BGV, we are excited to back Enterprise 4.0 startups that leverage AI, Automation and Unique datasets to drive massive value creation with global enterprises.”

“Saama is thrilled to lead the latest investment round in FirstHive,” noted Partner at Saama Capital Hemant Asher. “Our confidence in FirstHive stems from four key factors: the growing importance of first-party customer data for B2C and B2B brands, FirstHive’s proven track record with global enterprises, the platform’s ability to compete and win against respected global competitors, and the leadership team’s demonstrated maturity and results. We believe FirstHive is well-positioned for continued success.”

“We are incredibly excited to welcome Benhamou Global Ventures, Saama, and Amit Singal to the FirstHive family,” said Founder and CEO of FirstHive Aditya Bhamidipaty. “Their support and expertise will be invaluable as we embark on the next phase of our journey. This investment will enable us to expand our presence in the US market, extend platform capabilities, accelerate AI capabilities and ultimately deliver more value to our customers.”

FirstHive was previously backed by Arka Ventures (Blume, BGV, Emergent VC), New Wave Partners (VA, US), InfoEdge Ventures (India AIF), Mela Ventures, and angel investor Amit Midha, CEO, Alat.

About FirstHive

FirstHive, a premier global Customer Data Platform, is a tool for consumer marketing enterprises to consolidate all their opt-in first-party consumer data. Once deployed, FirstHive becomes the single source of truth of customer identity & data within the enterprise’s marketing and analytics ecosystem. FirstHive acts as the brain or system of intelligence by delivering seamless cross-tool & cross-channel communication for the marketing teams and with its out-of-the-box recommendation & assisted decision engine, directly enhances CX and marketing ROI objectives. FirstHive is based in California with operations and customers across the US, India, and ASEAN.  

Media Contact:
Ksenia Kulik
9193493786
[email protected] 

SOURCE FirstHive

Lead investor Emerson Collective champions Midi’s mission to expand access to expert, insurance-covered care for women in midlife and beyond

LOS ALTOS, Calif., April 24, 2024 — Midi Health, the fastest-growing virtual care clinic for women navigating perimenopause and menopause, today announced the close of a $60M Series B funding round led by Emerson Collective, bringing the company’s total funding raised to date to $100M. Additional investors include GV (Google Ventures), who led the previous funding round, along with Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, Gingerbread Capital, Able Partners, G9 and Operator Collective. They join a syndicate of primarily female-led investors including F7, Steel Sky Ventures, Avestria, Muse Capital, 1843 Capital, Anne Wojcicki, Susan Wojcicki, and K50 Ventures.

Women spend more than a third of their lives in perimenopause or menopause, with more than 1.2 billion women globally expected to be in these life stages by 2030. Upwards of 85 percent of women will experience menopausal symptoms that can negatively impact their productivity and quality of life, yet 75% of women who seek care for these symptoms do not receive any treatment. The primary reason is that only about 1 in 5 OB/GYNs, and even fewer primary care physicians, receive specialized menopause education or training.

“Historically, women’s healthcare has been neglected, with perimenopause and menopause having significant unmet needs,” said Fern Mandelbaum of Emerson Collective. “Midi is providing expert, empathetic care coupled with comprehensive insurance coverage, finally addressing this gap and ensuring that all women receive the support they need and deserve.”

A pioneer in the midlife women’s health space, Midi Health was founded in 2021 with a mission to close this care gap, and is now the fastest-growing virtual clinic focused on treating women in perimenopause and menopause. Over the past year, the company has cared for tens of thousands of patients, expanded to all 50 states, added Fortune 100 employers offering Midi as a workplace benefit, and launched partnerships with major healthcare systems such as Memorial Hermann and benefits platforms such as Progyny and Cleo.

The additional round of funding will allow Midi to expand insurance coverage (already established nationwide), hire and upskill an additional 150 clinicians by end of year, diversify service lines, amplify the conversation around midlife women’s healthcare, and scale to care for 1 million+ women per year by 2029.

The quality of Midi’s care is validated by a recent survey of 2,200 patients, in which: 

• 91% report overall symptom improvement within 2 months of their first Midi visit. Broken down for several symptoms:
  • 94% report improvement of hot flashes and night sweats within 3 months
  • 93% report improvement of insomnia within 5 months
  • 92% report improvement of moodiness, anxiety, and/or depression within 2 months
  • 89% report improvement of brain fog and memory lapses within 5 months

Midi shows similarly strong results for a number of other health concerns, and the clinical team is well positioned to meet many more needs for women between the ages of 35 and 65 over the course of 2024.

The new funding reflects a growing national awareness of women’s unmet healthcare challenges, and support for innovative solutions designed to fill care gaps. This year, President Biden signed an Executive Order aimed at advancing women’s health research and innovation, with a specific focus on menopause, and a groundswell of corporate employers have added menopause benefits. Midi has seized this unprecedented opportunity to transform midlife well-being for the 1 in 4 women in the U.S. over the age of 40. The benefits extend far beyond a patient population: Addressing the care gap for women in perimenopause and menopause can boost the average per capita GDP generated by women by 1.7%, contributing at least $1 trillion to the global economy by 2040 (Source: McKinsey Report).

“We started Midi with just one specific focus: helping women access world-class, expert perimenopause and menopause care, covered by insurance, and we have been at the forefront of delivering on that promise,” said Joanna Strober, CEO and Co-founder of Midi Health. “But what we have also learned is that addressing the health concerns of women in midlife is more complex than simply treating hot flashes and prescribing hormone replacement therapy. Midi takes a multi-symptom, holistic approach to care designed to help women live their best, most productive and fulfilling lives—whether that involves medication, lifestyle coaching, natural supplements, or other support. Our goal now is to expand services and scope to continue this comprehensive, personalized care far beyond menopause.”

For visual assets including photos and b-roll, visit https://www.joinmidi.com/press-room. For patient stories and more comments from Midi Health CEO Joanna Strober, visit joinmidi.com/series-b-announcement.

About Midi Health
Midi Health is the fastest growing virtual care clinic focused on women navigating midlife hormonal change and beyond. With treatment protocols created by world-class medical experts in perimenopause and menopause, delivered by clinicians trained in women’s midlife health, Midi Health provides patients with personalized care plans that include hormonal and non-hormonal medications, supplements, lifestyle coaching and more. All services are covered by insurance, and conveniently accessible through telehealth visits and 24/7 messaging. To learn more, visit www.joinmidi.com.

Media Contact:
Aimee Grove for Midi Health: [email protected]; 415-706-1906

SOURCE Midi Health

BEDFORD, Ohio, April 24, 2024 — Aropha, a leading laboratory focused on advancing biodegradable material discovery and testing through lab automation and AI predictive modeling, today announced that it has raised $1 million in a Series Seed funding round. The round was led by Comeback Capital, with participation from Lightbank and Right Side Capital Management (RSCM).

Aropha works directly with companies to provide rapid biodegradation testing and implement AI screening into their product development processes. The funding will be used to expand Aropha’s current laboratory operations, increase industry awareness, and fund the development of its biodegradation prediction model, ArophaAI.

“The timing could not be better for the innovation,” said Travis Johnston, Co-Founder, COO, and CRO, Aropha. “What we are seeing is the convergence of adequate predictive testing becoming technologically feasible for the first time and the environmental importance of biodegradation being recognized through increasing legislation.”

With over 145,000 tonnes of microplastics used in the EU each year and new legislation requiring 100% of single-use packaging to be recyclable or compostable by 2032 in California, the demand for cost-effective and efficient biodegradation testing is rapidly increasing. Aropha is well-positioned to significantly impact the testing industry, as even one of the most common, short biodegradation studies may cost over $10,000 according to the EPA with some complex, lab-based simulation tests reaching over $300,000.

To date, Aropha has helped more than 80 customers with their biodegradation testing through both in-lab and in-silico testing. Year-over-year booked revenue at the end of Q4 saw 190% growth. The company also recently published a free version of its predictive model, ArophaAI-2.

“This fundraising positions Aropha to be the market leader in the biodegradability testing category,” said Kuan Huang, Co-founder, CEO, and CTO, Aropha. “It will enhance our ability to act as a specialty lab for biodegradation that provides rapid, cost-effective physical testing, as well as enable us to develop the first commercially viable biodegradation prediction model that can be widely used across multiple industries and applications.”

Aropha plans to continue expanding its current testing facility, invest heavily in its predictive model development, and strengthen relationships with long-term partners and appropriate accreditation bodies.

Investor Confidence:

“Through the integration of artificial intelligence for material screening and the automation of laboratory processes, Aropha stands on the brink of markedly expediting the creation of environmentally benign materials. We are thrilled to support their mission and believe they have the potential to make a lasting impact on the industry.”
– Scott Shane, Managing Partner, Comeback Capital (https://www.comeback.vc/)

“Aropha’s unique approach to environmental testing has the potential to significantly impact how companies develop eco-friendly products. Their focus on biodegradability testing and future expansion into additional environmentally properties, combined with a market moving towards stricter environmental standards, positions them well as a valuable partner for companies in need of better environmental testing.”
– Eric Ong, Partner, Lightbank VC (https://www.lightbank.com/)

About Aropha
Aropha is a leading independent testing lab pioneering the application of AI modeling and lab automation to advance biodegradation testing. Its team brings together expertise in environmental engineering, chemistry, data science, and software engineering to create cost-effective, rapid biodegradability testing that saves companies months of development time and millions in testing costs. To learn more, please visit: https://www.aropha.com/.

PR Contact:
Nicole Gorman
Gorman Communications, for Aropha
508-397-0131
[email protected] 

SOURCE Aropha Inc.

HIGH POINT, N.C., April 24, 2024 — As more and more consumers search for wellness products, particularly in the area of gut health, recent research from the North Carolina A&T University and existing medical publications confirm that nearly all brewed coffee is a significant source of acid in consumer diets.  Puroast Coffee is the lone exception – all of the other brands tested were shown to have more than 4 times the amount of acid in their brews when compared to Puroast.

Puroast uses a proprietary method in their processing to reduce acid formation. This is important, as the high acid levels in regular coffee are now known to cause gut and other health problems.

A research team, headed by Dr. Salam Ibrahim, published in Bioactive Compounds in Health and Disease (Mar. ’24), tested several coffee brands including those claiming “low acid” on their packaging and brand promotion.  Almost all of these brands were found to have more than double the acid of the high acid/low acid line, the Critical pH, defined by the National Institute of Health (NIH), and the dental community.

Additional concern surrounds the brands labeled as low acid. The study found these coffees in fact have on average more acid than conventional coffee.  

Puroast Coffee was the only exception shown in the published results. This company claims low acid on its packaging and public promotion, and its claims were confirmed in the NC A&T findings. All other brands have on average four times more acid than Puroast. Dr. Taka Shibamoto, of UC Davis, says the “much lower acid levels in Puroast is a significant finding“.

Coffee is a well-known source of acid and health problems; WebMD.com lists coffee as the leading cause of heartburn, and Leena Khaitan, MD states, “…the worst beverage for Acid Reflux is coffee”. Registered Dietician Andrea Dunn says “The acid in coffee is causing gastrointestinal issues like heartburn, acid reflux and bloating”.

Mislabeling by certain coffee brands claiming low acid is a growing concern, particularly in light of the serious health risks coming from high acid diets.   As a result of these new findings regulatory agencies are expected to review this matter.  More on acid in coffee, and on Puroast verified low acid quality, and as an option to conventional high acid coffees, can be found at www.puroast.com.

SOURCE Puroast Coffee, Inc.

BforeAI autonomously maps and predicts malicious infrastructure through the ingestion of massive datasets, analyzing Internet metadata and establishing baselines to detect anomalies, deterring them before they turn into attacks. This unique capability empowers customers with a preemptive active defense posture that enables security teams to stop attacks before they are executed.

“BforeAI is automatically blocking thousands of attacks every day, this new round of funding boosts our ability to serve ever more sophisticated customers and drive value in a competitive market. Increasing digital fraud, scams and cyberattacks prove organizations can no longer rely only on a reactive approach: they need to preempt, disrupt and deter attacks,” said Luigi Lenguito, Founder and CEO of BforeAI.

With multiple AI/ML patents behind its technology, BforeAI specializes in predictive attack intelligence and automated digital risk protection services. The company’s mission is to proactively safeguard data, IT/OT networks, digital assets, customers, employees, and brand reputation. By using behavioral predictive intelligence, PreCrime™ monitors over 96% of the Internet to stay ahead of cyber threats, empowering organizations to effectively preempt risks days to weeks in advance of attack.

“The cybersecurity market is flush with solutions that help companies after an attack or breach has occurred. BforeAI is the first company to bring a predictive approach to improve organizations’ cyber posture. The unique ability to predict and stop a cybersecurity event before it happens and the thousands of direct integrations with service providers worldwide are clear differentiators in this crowded market,” said Jay Leek, Managing Partner and Co-founder of SYN Ventures and BforeAI Board Member.

“The combination of data and AI is leading to tremendous advances in the fight against attackers. Predicting where/when the attacker will be is the next level of cyber defense,” commented Richard Stiennon of IT-Harvest and leading industry analyst.

The BforeAI PreCrime™ subscription offering comprises both Intelligence and Brand solutions, designed to predict, preempt, and deter malicious campaigns before they impact your business; all with a 10 times contract value performance guarantee by Munich Re. This evolutionary learning technology is constantly improving anomaly identification to reduce false positives below 0.05%, enabling organizations to stop attacks in less than seven minutes.

Customers around the world are already turning to BforeAI, including large social media platforms, financial services organizations, and leading global manufacturers in the medical device, food service, and home electronics industries.

About BforeAI:

BforeAI is a pioneer in Predictive Attack Intelligence and Digital Risk Protection Services (DRPS). Using behavioral AI, our PreCrime™ platform aims to shift cyber defense from reactive to preemptive. With solutions for brand protection and threat intelligence, BforeAI is the industry’s fastest, most accurate automated online fraud protection.  To learn more, visit bfore.ai.

About SYN Ventures:

SYN Ventures is a venture capital firm focused on investing in disruptive and innovative security companies in the cybersecurity, industrial security, national defense, privacy, regulatory compliance, and data governance industries. The firm’s dedicated security team of former CISOs, CEOs and Founders has a proven track record with over 300 years of combined security investing and operational experience. SYN also has a highly distinguished network of seasoned security advisors and CISOs.

Media Contact:
Danielle Ostrovsky
Hi-Touch PR
[email protected]

SOURCE BforeAI

Company’s Annual Recurring Revenue up more than 100 percent; Achieves 200 percent growth on a 30 percent increase in headcount since last round of funding

BOSTON and DUBLIN, April 24, 2024 — Tines, the trusted leader in smart, secure workflows, today announced $50 million in new funding as an extension to its Series B led by Accel and Felicis with participation from Addition, CrowdStrike Falcon Fund and SVCI, all pre-existing investors in the company. This financing brings the total capital raised by Tines to date to $146.2 million.

In fiscal year 2024, Tines’ Annual Recurring Revenue (ARR) grew by over 100 percent, an increase of more than 200 percent since the company’s last funding round in October 2022 with a 30 percent increase in employee headcount. The new investment will enable Tines to continue to help its customers – which range from startups to the Fortune 10 – to enhance their workflow automation capabilities by expanding its functionality for collaborative workflows across the enterprise and adding AI enhancements for ease of use.

“Tines’ mission is to power the most important workflows for companies worldwide,” said Eoin Hinchy, co-founder and CEO at Tines. “These funds allow us to double down on areas we’ve seen much success, maintain our leadership position in security, and continue our strategy to automate complex technical workflows for multiple departments across the enterprise.”

Organizations burdened by the common challenge of too much work and not enough staff risk employee burnout and costly human errors, which can impact a company’s reputation and the bottom line. With Tines, teams can unlock new levels of efficiency through a combination of workflow automation, orchestration, and AI. This funding helps further Tines’ innovation roadmap, driven by customers’ feedback, to continue to make the platform easier to use and help customers realize meaningful value quickly.

“When we led Tines’ Series A in 2019, Eoin and Thomas had spent more than a decade as security operators, experiencing the inefficiencies and tedious manual tasks faced by teams everywhere firsthand,” said Luca Bocchio, partner at Accel. “The Tines team is now going after the broader opportunity of powering the most important and mission critical workflows for global businesses. We believe Tines represents the future for workflow automation in security and beyond and we look forward to the journey ahead.”

“Tines is a once-in-a generation platform that increases the efficiency of all the products it touches,” said Jake Storm, partner at Felicis. “The company has demonstrated phenomenal execution since we first invested in 2022, driven by intense customer love and a product that provides real value.”

The near-term strategy for Tines is to continue addressing the demands of large-scale operations for global enterprises, federal government and public sector customers. Today’s announcement builds on Tines’ recent momentum, such as the launch of its Channel Partner Program, which doubled the number of partners in its ecosystem in 2023, the expansion of its platform’s focus to include teams throughout an organization, and its recent product innovations including the release of new AI-powered features.

Tines is hiring across all departments, including engineering, product, operations, sales and marketing. Tines has offices in Dublin, Boston and San Francisco. More information on open positions can be found at www.tines.com/careers.

Tines will be exhibiting in Booth 4519 North at the RSA Conference being held at the Moscone Convention Center in San Francisco from May 6-9.

About Tines
Co-headquartered in Dublin and Boston, Tines offers the only workflow platform that delivers powerful automation and orchestration straight into the hands of any member of your organization. Tines brings an impact-first approach to all teams, securely running thousands of mission-critical workflows per day across a diverse range of customers, including Canva, Databricks, Elastic, Kayak, Mars, McKesson and Oak Ridge National Laboratory. The company has raised $146.2M in funding to date from investors including: Felicis, Addition, Accel, Blossom Capital and Lux Capital. To learn more about Tines, visit www.tines.com. 

Media Contact:
Brianna McGarry
Bateman Agency for Tines
[email protected] 

SOURCE Tines

With its worldwide unique SaaS solution for optimized, dynamic pricing, the German-based start-up is driving revenue and margins in the after-sales business of manufacturers.

ESSLINGEN, Germany, April 23, 2024 — Just in time for its fourth anniversary, MARKT-PILOT announces the successful completion of one of Europe’s largest Series A financing rounds, led by global software investor Insight Partners with participation from existing investor Capnamic. The Esslingen-based company will use the capital to further expand its business in Europe and the US, solidifying its position as a global player in the manufacturing market.

Since its founding in 2020, MARKT-PILOT has been revolutionizing the manufacturing industry with PRICERADAR, a unique global SaaS solution for market-based spare parts pricing. PRICERADAR automatically researches prices and delivery times of spare parts and thus shows customers their competitive position and sales potential. After PRICERADAR’s success, the company launched its second product, PRICEGUIDE, in 2023 – a solution that provides optimized and validated price recommendations for customers’ spare parts portfolio.

Jessie Sheff, Vice President at Insight Partners, will join MARKT-PILOT’s board. “With its innovative software solutions, MARKT-PILOT offers manufacturing companies around the world previously unimagined potential in terms of revenue, margins, and customer loyalty. The entire industry stands to benefit from the full market transparency that MARKT-PILOT provides, and we were particularly impressed by the strong customer feedback and the company’s uncontested position in the market,” said Sheff.

Alex Morbe, CEO of MARKT-PILOT, has roots in manufacturing and knows the industry’s needs inside and out. Morbe’s focus for the future is on dynamic pricing and continuing to build close connections with customers.

“More than 100 customers have recorded a more than 20% average increase in sales of their spare parts as a result of using MARKT-PILOT’s software solution. It’s the ultimate vote of confidence in our results and the viability of our business model that one of the world’s most visionary tech investors has placed their trust in us,” said Morbe. “With the support of Insight Partners, we will continue to expand and invest in the further development of our products and AI.”

Dr. Martin Ruth, CFO of MARKT-PILOT, is also delighted with the successful Series A round and calls to (future) employees: “We are very proud of our great, highly motivated team in Esslingen, Chicago, Milan and Stockholm. Now we have the opportunity to further grow and attract more talent to our company.”

About MARKT-PILOT
MARKT-PILOT solves the biggest challenge in the service and after-sales business of machine manufacturers and enables market-oriented spare parts pricing through automated market price research. The globally unique SaaS solution is based on many years of experience in machine manufacturing and after-sales and creates full market transparency for the first time regarding the offer, prices, and delivery times of spare parts. Machine manufacturers benefit from previously untapped potential in the spare parts business, can work on data, and react proactively to market dynamics. The result: more sales and customer satisfaction. MARKT-PILOT was founded in 2020 and currently employs over 130 people. More than 100 customers are already working with the software solutions. The company is headquartered in Esslingen, Germany, and currently has three additional locations in Chicago, Milan and Stockholm. For more information, see markt-pilot.com

About Insight Partners
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2023, the firm has over $80B in regulatory assets under management. Insight Partners has invested in more than 800 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has offices in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

About Capnamic
Capnamic is a leading European early-stage Venture Capital firm, with offices in Cologne, Berlin, and Munich. The VC invests in outstanding teams from the German-speaking regions from Pre-Seed up to Series A. Capnamic’s investments include companies such as LeanIX (exit to SAP), Staffbase, Adjust (exit to Applovin) parcelLab or Capmo, amongst others. All portfolio companies can rely on Capnamic’s unique network of global investors and industry partners as well as hands-on support, mentoring and knowledge exchange. The vast expertise of the Capnamic team includes more than 100 investments, a high turnover of successful trade sales and IPOs, as well as a strong entrepreneurial track record within the investment team. The general partners are Christian Siegele, Christian Knott, Jörg Binnenbrücker and Olaf Jacobi. For more information, see Capmanic.com

SOURCE MARKT-PILOT

Founded in 2023, OUNO rapidly gained traction in the market, attracting early investments from notable figures such as England & Manchester United’s Mason Mount, BAFTA-winning actor Michael Ward, and Grind Founder David Abramovitch, among others. In its inaugural year, OUNO demonstrated remarkable progress, earning the trust of numerous high-end brands including Prada, Hublot, and the Soho House Group. With thousands of daily B2C users in London alone, OUNO has established itself as a leader in the executive ride-hailing sector.

OUNO’s innovative feature of vehicle specificity distinguishes it in the executive ride-hailing space. Unlike other platforms that generalize vehicle options, OUNO enables users to request specific models such as Mercedes E-Class, S-Class, V-Class, or even a Tesla for those seeking a fully electric option. With over 2,500 chauffeurs already enlisted on the platform and an additional 1,500 awaiting onboarding, OUNO has become the preferred choice for drivers in London.

TRAM VF’s investment underscores its confidence in OUNO’s growth potential and commitment to innovation. With ambitious plans for expansion into the MENA region and the US, OUNO is positioned to redefine urban transportation globally. TRAM’s leadership is excited to support OUNO’s journey as it continues to lead the London market and extend its reach worldwide.

“We’re delighted to welcome TRAM to our business and successfully close our seed round,” said Bobby Drewett, Founder of OUNO. “Having TRAM as our first VC investor will strengthen our position for future funding rounds, benefiting from their wealth of knowledge and experience.”

“The strategic expansion into the Middle East is a top priority for both TRAM and OUNO,” remarked Asad Ali, Managing Partner of TRAM VF. “As I transition from public markets to private markets, I look forward to closely collaborating with Bobby and the OUNO team. As a value-add investor, I’ll utilize Tri Ri’s global network and resources to support OUNO’s growth, particularly in key markets, and help solidify its position as a market innovator in executive transportation.”

OUNO’s innovative transportation approach, coupled with TRAM VF’s strategic investment, lays the groundwork for a dynamic partnership poised to revolutionize the travel experience. Together, OUNO and TRAM VF are set to reshape urban mobility and make a lasting impact worldwide.

SOURCE Tri Ri Asset Management

NEW YORK, April 23, 2024 — Summer Health, a digital health company offering 24/7 pediatric support to parents, announced $11.65M in Series A Funding, co-led by new investor 7wire Ventures and returning investor Lux Capital. Returning investors Sequoia Capital, Metrodora Ventures, Box Group, and Shrug Capital participated, with new participation from Pivotal Ventures, a Melinda French Gates company and Leaps by Bayer. Alfred Lin of Sequoia Capital, Deena Shakir of Lux Capital, Alyssa Jaffee of 7wire Ventures, and Chelsea Clinton of Metrodora Ventures are also joining the Summer board.

Summer Health is a text-based companion to a family’s primary pediatrician, removing the need for unnecessary visits and serving as support anytime and anywhere. The company’s flagship product, text-based care in under 15 minutes, has been used by thousands of parents to manage urgent medical guidance and seamlessly prescribe medications as-needed since its launch in July 2022. In November 2023, the company expanded its longitudinal primary care model with lactation support, sleep training, developmental milestone tracking, and long-term pediatric care.

Today, parents can buy Summer Health’s services directly from the company for $45 a month or via their employer at select businesses.

Summer Health’s clinical team is led by Dr. Ali Alhassani, MD F.A.A.P. He notes that the most common needs parents address with Summer include:

• Nutrition-related questions, including breastfeeding and the introduction of solid foods;
• Pink eye and rashes;
• Allergies and food-related sensitivities;
• Support with sleep training;
• Support following Well-Child care visits, which typically only last 6 to 8 minutes.

The Association of American Medical Colleges projects a doctor shortage of up to 86,000 physicians and that extends to pediatrics by 2036. Summer Health plans to double down on its distribution via consumer and employer channels to combat this lack of abundant access to pediatricians. The company will also continue to expand service offerings for parents. In addition to primary care, they currently offer specialty services like nutrition and child development coaching.

“Summer Health was created by parents, for parents, to make daily life just a little bit simpler. What’s so special about this group of investors is that they’re all parents, and every single one of them actively uses the product,” said Summer Health’s CEO Ellen DaSilva.

“As a pediatrician, I’ve witnessed first-hand how long parents would need to wait for appointments for their child to be seen in person,” said Dr. Ali Alhassani, head of clinical for Summer Health. “So many of these issues could be addressed from the comfort of home, and that’s why I joined Summer Health.”

Summer Health’s trusted brand has laid the groundwork for deep longitudinal care for all families. On a personal note, I’ve been using the service since Day One and can’t imagine life without it,” said Alyssa Jaffee, general partner with 7wire Ventures. “Professionally, we are delighted to be part of Summer Health’s journey as it scales to more parents and their families, and we deeply believe in the need for more investment and innovation in pediatrics.”

“Summer Health’s growth is evidence that the company has tapped into a real and growing need,” said Deena Shakir, general partner at Lux. And “I’m proud to say that this round is being co-led by two moms of three kids and the company led by another—between us, 9 children and a lifetime of user feedback.

For press inquiries, contact [email protected]

SOURCE Summer Health